id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-279056-mmcoqtb5	Seirafianpour, Farnoosh	Cutaneous manifestations and considerations in COVID‐19 pandemic: A systematic review	2020-07-08		.txt	text/plain	4651	262	46	BACKGROUND: COVID‐19 had a great impact on medical approaches among dermatologist OBJECTIVE: This systematic review focuses on all skin problems related to COVID‐19, including primary and secondary COVID‐related cutaneous presentations and the experts recommendations about dermatological managements especially immunomodulators usage issues METHOD: Search was performed on PubMed, Scopus, Embase and ScienceDirect. Totally 5 article were about skin drug reactions of COVID-19 treatments; two of them were original studies as case reports that were summarized in Table 7 (in the supplement file). In overall, non-infected non-at risk patients with immune-medicated dermatologic disorders under usage of immunosuppressive immunomodulator drugs like biologic agents are not needed to be alter regimen or discontine the therapies during pandemic, even these drugs may control the deteriorating cytokine storms also prevented disease flare-ups which both were associated with poorer outcomes and more complications in COVID-19 course, although strict adherence to quarantine and personal-social preventive hygiene performances are highly recommended especially in these groups of patients.	./cache/cord-279056-mmcoqtb5.txt	./txt/cord-279056-mmcoqtb5.txt